Drug-development CRO · CDMO · Chemical synthesis
WuXi AppTec
A global CRO/CDMO providing chemistry, drug discovery, and development services to pharmaceutical companies worldwide. Hang Seng Index constituent. Baseline node ahead of value-chain research; promoted to a full node once AI question demand is observed.
Business categories Biopharma Manufacturing & CDMO · Biopharma & Life Sciences · primary
Other companies in the same category
- Biopharma Manufacturing & CDMO: Fujifilm Holdings · Samsung Biologics · ST Pharm · WuXi Biologics · Thermo Fisher Scientific
2359.HK Updated Jul 11, 2026 3 AI consumers· 1 recurring
Annual return · 2026-09-04'21-27.8%'22-8%'23-46%'24+5.1%'25+104.4%YTD+74.6%
Money in ▸·
WuXi AppTecapprox. CN¥40.3B
▸ Money out·
Financials & Segments
- Total revenue · approx. CN¥40.3B (FY2023)
- Segments · WuXi Chemistry · Testing · Biologics & cell/gene therapy
Revenue from
No refined links yet.
Pays to
No refined links yet.